交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

許景桓 2026 Mar 28, 00:00

地緣政治動盪重塑美元策略,挑戰其傳統主導地位

張瑋庭 2026 Mar 28, 00:00

地緣政治緊張與經濟逆風下,電動車市場面臨消費者猶豫

許景桓 2026 Mar 27, 00:00

美元匯率展望:利差收窄與經濟逆風下,美元恐走弱

張瑋庭 2026 Mar 27, 00:00

聯準會資產負債表縮減之路:一場需要多年改革的挑戰

盧昕穎 2026 Mar 26, 00:00

伊朗霍爾木茲海峽「校準策略」引擔憂:全球石油市場低估供應短缺風險

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
林芷柔 2026 Mar 28, 00:00

以色列策略轉向:聚焦摧毀伊朗軍工產業,以求停火前重創

林芷柔 2026 Mar 28, 00:00

特朗普週末市場操盤術:『週六驚魂』策略及其全球金融影響

許景桓 2026 Mar 28, 00:00

特朗普簽名新版美元紙幣問世:開創美國貨幣歷史先河

盧昕穎 2026 Mar 28, 00:00

市場分析:地緣政治變局與經濟前景展望

陳昊然 2026 Mar 28, 00:00

烏克蘭資金告急:防禦能力面臨嚴峻考驗與地緣政治影響

陳昊然 2026 Mar 28, 00:00

參議員華倫尖銳質疑華許出任美聯儲主席提名,鮑威爾調查案添變數

林芷柔 2026 Mar 28, 00:00

伊朗核爭議加劇:面對打擊,尋求核武論調日漸公開

陳昊然 2026 Mar 28, 00:00

中東衝突引爆全球市場拋售潮:前所未有的金融動盪

聯絡方式

點差

0.37

點差(%)

0.6338 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

119523196928

流通股份

2041735455

收益日期(下一個)

2001-08-07

現金殖利率 

2026-05-01

除息日

2026-04-02

遠期年股息率

2.52

遠期年現金殖利率

0.0424

每股盈餘

3.46

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot